Gilda da Cunha Santos

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

Ming‐Sound Tsao, Akira Sakurada, Jean-Claude Cutz et al. · New England Journal of Medicine · 2005 · 1.8K citations

Role of <i>KRAS</i> and <i>EGFR</i> As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21

Chang‐Qi Zhu, Gilda da Cunha Santos, Keyue Ding et al. · Journal of Clinical Oncology · 2008 · 665 citations · Full text

A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer

Kazuhiro Yasufuku, Andrew Pierre, Gail Darling et al. · Journal of Thoracic and Cardiovascular Surgery · 2011 · 545 citations · Full text

Medicine, Mediastinal Lymph, Thoracic Ultrasound +6

Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer

Chétana Lim, Ming‐Sound Tsao, Lisa W. Le et al. · Annals of Oncology · 2015 · 234 citations · Full text

Biomarker (Medicine), Prognostic Biomarkers, Oncology +11

First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial

Cesare Gridelli, Fortunato Ciardiello, Ciro Gallo et al. · Journal of Clinical Oncology · 2012 · 232 citations · Full text